🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will look at the change in the participant's body weight from th...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-06-04
Trial ID
NCT03552757
Treatments Being Tested
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
Start Date
2025-04
Trial ID
NCT06894784
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
This study is a randomized, open-label, single-dose, parallel-controlled bi...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2024-09-22
Trial ID
NCT06634927
This study is a prospective, randomized, open-label clinical trial enrollin...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-06-02
Trial ID
NCT07293325
Treatments Being Tested
The researchers are doing this study is to find out whether tirzepatide and...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2024-12-19
Trial ID
NCT06751589
Treatments Being Tested
The specific aim of this study is to examine the Safety, Tolerability and P...
Status
Recruiting
Location
Frontage Clinical Services, Inc.
Start Date
2026-03-02
Trial ID
NCT07465965
Treatments Being Tested
Title: Body fluid proteome SIGnatures for persoNALised intervention to pre...
Status
Enrolling By Invitation
Location
Steno Diabetes Center Copenhagen
Start Date
2025-11-20
Trial ID
NCT06954090
Treatments Being Tested
This study will look at how well CagriSema helps people living with obesity...
Status
Active Not Recruiting
Location
FDRC
Start Date
2025-06-03
Trial ID
NCT07011667
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is an appr...
Status
Recruiting
Location
Mapi pharma Investigational Site ISR001
Start Date
2026-08-09
Trial ID
NCT07563699
Treatments Being Tested